Correct histological classification of the tumor is only the first step in the modern diagnosis and treatment of the patient. Genomic pathology requires that one correlates the molecular profile with the structural phenotype.
A 29-year-old man, previously in excellent health, presented with a progressively enlarging mass on the lower back of one-year’s duration. What would be the best initial course of action at this point?
A 26-year-old man was diagnosed with the nodular sclerosing subtype of Hodgkin lymophoma, stage II-A. He was started on cyclic combination chemotherapy consisting of adriamycin, bleomycin, vinblastine, and dacarbazine ("ABVD" therapy).